(Q44985420)

English

A randomized, open-label, comparative study of simvastatin plus diet versus diet alone on angiographic retardation of coronary atherosclerosis in adult Japanese patients: Japanese utilization of simvastatin therapy (JUST) study

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

A randomized, open-label, comparative study of simvastatin plus diet versus diet alone on angiographic retardation of coronary atherosclerosis in adult Japanese patients: Japanese utilization of simvastatin therapy (JUST) study (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

object named as

Yasuo Ohashi

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

author name string

Kyoichi Mizuno

1

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Haruo Nakamura

2

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Tsuneo Kaburagi

4

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Akira Kitabatake

5

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Toshihiko Tochihara

6

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Saichi Hosoda

7

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

JUST Study Investigators

8

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

publication date

1 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

878-888

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990131-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990131-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990131-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990131-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990131-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990131-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients. Harvard Atherosclerosis Reversibility Project (HARP) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990131-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS])

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990131-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Serial quantitative coronary angiography and coronary events

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990131-2

7 January 2021

based on heuristic

inferred from DOI database lookup

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990131-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990131-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative coronary angiography to measure progression and regression of coronary atherosclerosis. Value, limitations, and implications for clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990131-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990131-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990131-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990131-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990131-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990131-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of simvastatin on progression of coronary artery disease. The Multicenter coronary Intervention Study (CIS).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990131-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990131-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of lipid lowering therapy on progression of coronary and carotid artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990131-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipid-lowering interventions in angiographic trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990131-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of progression of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990131-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The seven countries study: 2,289 deaths in 15 years

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990131-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Coronary heart disease mortality among men aged 35-44 years by prefecture in Japan in 1995-1999 compared with that among white men aged 35-44 by state in the United States in 1995-1998: vital statistics data in recent birth cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990131-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Trend of coronary heart disease and its relationship to risk factors in a Japanese population: a 26-year follow-up, Hiroshima/Nagasaki study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990131-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(04)90131-2

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44985420&oldid=2268376304"